Diabetic Macular Edema

EP. 6: Longer-Acting DME Drugs Ease Burden, Not Vision: John Kitchens, MD

August 3rd 2026

John Kitchens, MD, explores how GLP-1s, novel drug pipelines, and Medicaid access gaps are shaping the future of DME management.

EP. 5: Anti-VEGF Has Hit Its DME Ceiling: John Kitchens, MD

ByLaura Joszt, MA,John Kitchens, MD

July 27th 2026

Anti-VEGF has maxed out in diabetic macular edema (DME), but Ang-2 and Wnt pathway approaches could target disease differently, said John Kitchens, MD.

EP. 4: How Insurance, Socioeconomic Barriers Derail DME Care: Sunir J. Garg, MD

ByLaura Joszt, MA,Sunir Garg, MD

June 29th 2026

Insurance and socioeconomic factors delay optimal anti-VEGF care for diabetic macular edema, worsening vision disparities.

EP. 3: Catching DME Patients Before They Fall Off the Radar: Sunir Garg, MD

ByLaura Joszt, MA,Sunir Garg, MD

June 22nd 2026

Hidden costs, travel, and dilation can derail DME care, but clinicians can build adherence plans that keep working adults on vision-saving therapy.

EP. 2: The Structural and Scientific Gaps Still Undermining DME Care: Rahul Khurana, MD

ByLaura Joszt, MA,Rahul Khurana, MD

June 15th 2026

Real-world DME care falls short from missed anti-VEGF loading; sustained delivery, neuroprotection, and better primary care coordination promise gains.

EP. 1: Addressing the Real-World Gaps in Diabetic Macular Edema Care: Rahul Khurana, MD

ByLaura Joszt, MA,Rahul Khurana, MD

June 8th 2026

Real-world diabetic macular edema care lags trials as fewer VEGF injections and step therapy limit outcomes.

Diabetic Macular Edema

EP. 6: Longer-Acting DME Drugs Ease Burden, Not Vision: John Kitchens, MD

EP. 5: Anti-VEGF Has Hit Its DME Ceiling: John Kitchens, MD

EP. 4: How Insurance, Socioeconomic Barriers Derail DME Care: Sunir J. Garg, MD

EP. 3: Catching DME Patients Before They Fall Off the Radar: Sunir Garg, MD

EP. 2: The Structural and Scientific Gaps Still Undermining DME Care: Rahul Khurana, MD

EP. 1: Addressing the Real-World Gaps in Diabetic Macular Edema Care: Rahul Khurana, MD

Trending on AJMC

Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps

$20 Billion National Strategy Aims to Close the Women's Health Gap

Gene Therapy for Wet AMD Near an Inflection Point: Arshad Khanani, MD

Senate Unveils Sweeping Bill to Reform 340B Drug Program

Severe Eczema More Than Doubles Shingles Risk

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Diabetic Macular Edema

EP. 6: Longer-Acting DME Drugs Ease Burden, Not Vision: John Kitchens, MD

EP. 5: Anti-VEGF Has Hit Its DME Ceiling: John Kitchens, MD

EP. 4: How Insurance, Socioeconomic Barriers Derail DME Care: Sunir J. Garg, MD

EP. 3: Catching DME Patients Before They Fall Off the Radar: Sunir Garg, MD

EP. 2: The Structural and Scientific Gaps Still Undermining DME Care: Rahul Khurana, MD

EP. 1: Addressing the Real-World Gaps in Diabetic Macular Edema Care: Rahul Khurana, MD

Trending on AJMC

Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps

$20 Billion National Strategy Aims to Close the Women's Health Gap

Gene Therapy for Wet AMD Near an Inflection Point: Arshad Khanani, MD

Senate Unveils Sweeping Bill to Reform 340B Drug Program

Severe Eczema More Than Doubles Shingles Risk